0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Morquio Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-34H5635
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Morquio Syndrome Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Morquio Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-34H5635
Report
October 2024
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Morquio Syndrome Treatment - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Morquio Syndrome Treatment - Market

Morquio Syndrome Treatment - Market

Morquio syndrome is a type of mucopolysaccharide metabolic disorder, that is, type Ⅳ in mucopolysaccharide storage disease, also known as hereditary cartilage dystrophy syndrome
The global market for Morquio Syndrome Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Morquio Syndrome Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Morquio Syndrome Treatment by region & country, by Type, and by Application.
The Morquio Syndrome Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Morquio Syndrome Treatment.
Market Segmentation

Scope of Morquio Syndrome Treatment - Market Report

Report Metric Details
Report Name Morquio Syndrome Treatment - Market
CAGR 5%
Segment by Type:
  • Morquio A
  • Morquio B
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioMarin, Genzyme Corporation,, Shire, JCR Pharmaceuticals, Sanofi, Sangamo Therapeutics, Green Cross, Concert Pharmaceuticals, Alexion Pharmaceuticals, Roche, Pfizer, Lupin, Cambrex Corporation, Cipla, Bayer, Daiichi Sankyo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Morquio Syndrome Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Morquio Syndrome Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Morquio Syndrome Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Morquio Syndrome Treatment - Market report?

Ans: The main players in the Morquio Syndrome Treatment - Market are BioMarin, Genzyme Corporation,, Shire, JCR Pharmaceuticals, Sanofi, Sangamo Therapeutics, Green Cross, Concert Pharmaceuticals, Alexion Pharmaceuticals, Roche, Pfizer, Lupin, Cambrex Corporation, Cipla, Bayer, Daiichi Sankyo

What are the Application segmentation covered in the Morquio Syndrome Treatment - Market report?

Ans: The Applications covered in the Morquio Syndrome Treatment - Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Morquio Syndrome Treatment - Market report?

Ans: The Types covered in the Morquio Syndrome Treatment - Market report are Morquio A, Morquio B

1 Market Overview
1.1 Morquio Syndrome Treatment Product Introduction
1.2 Global Morquio Syndrome Treatment Market Size Forecast
1.3 Morquio Syndrome Treatment Market Trends & Drivers
1.3.1 Morquio Syndrome Treatment Industry Trends
1.3.2 Morquio Syndrome Treatment Market Drivers & Opportunity
1.3.3 Morquio Syndrome Treatment Market Challenges
1.3.4 Morquio Syndrome Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Morquio Syndrome Treatment Players Revenue Ranking (2023)
2.2 Global Morquio Syndrome Treatment Revenue by Company (2019-2024)
2.3 Key Companies Morquio Syndrome Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Morquio Syndrome Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Morquio Syndrome Treatment
2.6 Morquio Syndrome Treatment Market Competitive Analysis
2.6.1 Morquio Syndrome Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Morquio Syndrome Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Morquio Syndrome Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Morquio A
3.1.2 Morquio B
3.2 Global Morquio Syndrome Treatment Sales Value by Type
3.2.1 Global Morquio Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Morquio Syndrome Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Morquio Syndrome Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Morquio Syndrome Treatment Sales Value by Application
4.2.1 Global Morquio Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Morquio Syndrome Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Morquio Syndrome Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Morquio Syndrome Treatment Sales Value by Region
5.1.1 Global Morquio Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Morquio Syndrome Treatment Sales Value by Region (2019-2024)
5.1.3 Global Morquio Syndrome Treatment Sales Value by Region (2025-2030)
5.1.4 Global Morquio Syndrome Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Morquio Syndrome Treatment Sales Value, 2019-2030
5.2.2 North America Morquio Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Morquio Syndrome Treatment Sales Value, 2019-2030
5.3.2 Europe Morquio Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Morquio Syndrome Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Morquio Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Morquio Syndrome Treatment Sales Value, 2019-2030
5.5.2 South America Morquio Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Morquio Syndrome Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Morquio Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Morquio Syndrome Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Morquio Syndrome Treatment Sales Value
6.3 United States
6.3.1 United States Morquio Syndrome Treatment Sales Value, 2019-2030
6.3.2 United States Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Morquio Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Morquio Syndrome Treatment Sales Value, 2019-2030
6.4.2 Europe Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Morquio Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Morquio Syndrome Treatment Sales Value, 2019-2030
6.5.2 China Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Morquio Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Morquio Syndrome Treatment Sales Value, 2019-2030
6.6.2 Japan Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Morquio Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Morquio Syndrome Treatment Sales Value, 2019-2030
6.7.2 South Korea Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Morquio Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Morquio Syndrome Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Morquio Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Morquio Syndrome Treatment Sales Value, 2019-2030
6.9.2 India Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Morquio Syndrome Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BioMarin
7.1.1 BioMarin Profile
7.1.2 BioMarin Main Business
7.1.3 BioMarin Morquio Syndrome Treatment Products, Services and Solutions
7.1.4 BioMarin Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 BioMarin Recent Developments
7.2 Genzyme Corporation,
7.2.1 Genzyme Corporation, Profile
7.2.2 Genzyme Corporation, Main Business
7.2.3 Genzyme Corporation, Morquio Syndrome Treatment Products, Services and Solutions
7.2.4 Genzyme Corporation, Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Genzyme Corporation, Recent Developments
7.3 Shire
7.3.1 Shire Profile
7.3.2 Shire Main Business
7.3.3 Shire Morquio Syndrome Treatment Products, Services and Solutions
7.3.4 Shire Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 JCR Pharmaceuticals Recent Developments
7.4 JCR Pharmaceuticals
7.4.1 JCR Pharmaceuticals Profile
7.4.2 JCR Pharmaceuticals Main Business
7.4.3 JCR Pharmaceuticals Morquio Syndrome Treatment Products, Services and Solutions
7.4.4 JCR Pharmaceuticals Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 JCR Pharmaceuticals Recent Developments
7.5 Sanofi
7.5.1 Sanofi Profile
7.5.2 Sanofi Main Business
7.5.3 Sanofi Morquio Syndrome Treatment Products, Services and Solutions
7.5.4 Sanofi Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Sanofi Recent Developments
7.6 Sangamo Therapeutics
7.6.1 Sangamo Therapeutics Profile
7.6.2 Sangamo Therapeutics Main Business
7.6.3 Sangamo Therapeutics Morquio Syndrome Treatment Products, Services and Solutions
7.6.4 Sangamo Therapeutics Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Sangamo Therapeutics Recent Developments
7.7 Green Cross
7.7.1 Green Cross Profile
7.7.2 Green Cross Main Business
7.7.3 Green Cross Morquio Syndrome Treatment Products, Services and Solutions
7.7.4 Green Cross Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Green Cross Recent Developments
7.8 Concert Pharmaceuticals
7.8.1 Concert Pharmaceuticals Profile
7.8.2 Concert Pharmaceuticals Main Business
7.8.3 Concert Pharmaceuticals Morquio Syndrome Treatment Products, Services and Solutions
7.8.4 Concert Pharmaceuticals Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Concert Pharmaceuticals Recent Developments
7.9 Alexion Pharmaceuticals
7.9.1 Alexion Pharmaceuticals Profile
7.9.2 Alexion Pharmaceuticals Main Business
7.9.3 Alexion Pharmaceuticals Morquio Syndrome Treatment Products, Services and Solutions
7.9.4 Alexion Pharmaceuticals Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Alexion Pharmaceuticals Recent Developments
7.10 Roche
7.10.1 Roche Profile
7.10.2 Roche Main Business
7.10.3 Roche Morquio Syndrome Treatment Products, Services and Solutions
7.10.4 Roche Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Roche Recent Developments
7.11 Pfizer
7.11.1 Pfizer Profile
7.11.2 Pfizer Main Business
7.11.3 Pfizer Morquio Syndrome Treatment Products, Services and Solutions
7.11.4 Pfizer Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Pfizer Recent Developments
7.12 Lupin
7.12.1 Lupin Profile
7.12.2 Lupin Main Business
7.12.3 Lupin Morquio Syndrome Treatment Products, Services and Solutions
7.12.4 Lupin Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Lupin Recent Developments
7.13 Cambrex Corporation
7.13.1 Cambrex Corporation Profile
7.13.2 Cambrex Corporation Main Business
7.13.3 Cambrex Corporation Morquio Syndrome Treatment Products, Services and Solutions
7.13.4 Cambrex Corporation Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 Cambrex Corporation Recent Developments
7.14 Cipla
7.14.1 Cipla Profile
7.14.2 Cipla Main Business
7.14.3 Cipla Morquio Syndrome Treatment Products, Services and Solutions
7.14.4 Cipla Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 Cipla Recent Developments
7.15 Bayer
7.15.1 Bayer Profile
7.15.2 Bayer Main Business
7.15.3 Bayer Morquio Syndrome Treatment Products, Services and Solutions
7.15.4 Bayer Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.15.5 Bayer Recent Developments
7.16 Daiichi Sankyo
7.16.1 Daiichi Sankyo Profile
7.16.2 Daiichi Sankyo Main Business
7.16.3 Daiichi Sankyo Morquio Syndrome Treatment Products, Services and Solutions
7.16.4 Daiichi Sankyo Morquio Syndrome Treatment Revenue (US$ Million) & (2019-2024)
7.16.5 Daiichi Sankyo Recent Developments
8 Industry Chain Analysis
8.1 Morquio Syndrome Treatment Industrial Chain
8.2 Morquio Syndrome Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Morquio Syndrome Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Morquio Syndrome Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Morquio Syndrome Treatment Market Trends
    Table 2. Morquio Syndrome Treatment Market Drivers & Opportunity
    Table 3. Morquio Syndrome Treatment Market Challenges
    Table 4. Morquio Syndrome Treatment Market Restraints
    Table 5. Global Morquio Syndrome Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Morquio Syndrome Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Morquio Syndrome Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Morquio Syndrome Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Morquio Syndrome Treatment
    Table 10. Global Morquio Syndrome Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Morquio Syndrome Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Morquio Syndrome Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Morquio Syndrome Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Morquio Syndrome Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Morquio Syndrome Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Morquio Syndrome Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Morquio Syndrome Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Morquio Syndrome Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Morquio Syndrome Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Morquio Syndrome Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Morquio Syndrome Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Morquio Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Morquio Syndrome Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Morquio Syndrome Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Morquio Syndrome Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Morquio Syndrome Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Morquio Syndrome Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Morquio Syndrome Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Morquio Syndrome Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. BioMarin Basic Information List
    Table 32. BioMarin Description and Business Overview
    Table 33. BioMarin Morquio Syndrome Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Morquio Syndrome Treatment Business of BioMarin (2019-2024)
    Table 35. BioMarin Recent Developments
    Table 36. Genzyme Corporation, Basic Information List
    Table 37. Genzyme Corporation, Description and Business Overview
    Table 38. Genzyme Corporation, Morquio Syndrome Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Genzyme Corporation, (2019-2024)
    Table 40. Genzyme Corporation, Recent Developments
    Table 41. Shire Basic Information List
    Table 42. Shire Description and Business Overview
    Table 43. Shire Morquio Syndrome Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Shire (2019-2024)
    Table 45. Shire Recent Developments
    Table 46. JCR Pharmaceuticals Basic Information List
    Table 47. JCR Pharmaceuticals Description and Business Overview
    Table 48. JCR Pharmaceuticals Morquio Syndrome Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Morquio Syndrome Treatment Business of JCR Pharmaceuticals (2019-2024)
    Table 50. JCR Pharmaceuticals Recent Developments
    Table 51. Sanofi Basic Information List
    Table 52. Sanofi Description and Business Overview
    Table 53. Sanofi Morquio Syndrome Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Sanofi (2019-2024)
    Table 55. Sanofi Recent Developments
    Table 56. Sangamo Therapeutics Basic Information List
    Table 57. Sangamo Therapeutics Description and Business Overview
    Table 58. Sangamo Therapeutics Morquio Syndrome Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Sangamo Therapeutics (2019-2024)
    Table 60. Sangamo Therapeutics Recent Developments
    Table 61. Green Cross Basic Information List
    Table 62. Green Cross Description and Business Overview
    Table 63. Green Cross Morquio Syndrome Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Green Cross (2019-2024)
    Table 65. Green Cross Recent Developments
    Table 66. Concert Pharmaceuticals Basic Information List
    Table 67. Concert Pharmaceuticals Description and Business Overview
    Table 68. Concert Pharmaceuticals Morquio Syndrome Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Concert Pharmaceuticals (2019-2024)
    Table 70. Concert Pharmaceuticals Recent Developments
    Table 71. Alexion Pharmaceuticals Basic Information List
    Table 72. Alexion Pharmaceuticals Description and Business Overview
    Table 73. Alexion Pharmaceuticals Morquio Syndrome Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Alexion Pharmaceuticals (2019-2024)
    Table 75. Alexion Pharmaceuticals Recent Developments
    Table 76. Roche Basic Information List
    Table 77. Roche Description and Business Overview
    Table 78. Roche Morquio Syndrome Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Roche (2019-2024)
    Table 80. Roche Recent Developments
    Table 81. Pfizer Basic Information List
    Table 82. Pfizer Description and Business Overview
    Table 83. Pfizer Morquio Syndrome Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Pfizer (2019-2024)
    Table 85. Pfizer Recent Developments
    Table 86. Lupin Basic Information List
    Table 87. Lupin Description and Business Overview
    Table 88. Lupin Morquio Syndrome Treatment Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Lupin (2019-2024)
    Table 90. Lupin Recent Developments
    Table 91. Cambrex Corporation Basic Information List
    Table 92. Cambrex Corporation Description and Business Overview
    Table 93. Cambrex Corporation Morquio Syndrome Treatment Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Cambrex Corporation (2019-2024)
    Table 95. Cambrex Corporation Recent Developments
    Table 96. Cipla Basic Information List
    Table 97. Cipla Description and Business Overview
    Table 98. Cipla Morquio Syndrome Treatment Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Cipla (2019-2024)
    Table 100. Cipla Recent Developments
    Table 101. Bayer Basic Information List
    Table 102. Bayer Description and Business Overview
    Table 103. Bayer Morquio Syndrome Treatment Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Bayer (2019-2024)
    Table 105. Bayer Recent Developments
    Table 106. Daiichi Sankyo Basic Information List
    Table 107. Daiichi Sankyo Description and Business Overview
    Table 108. Daiichi Sankyo Morquio Syndrome Treatment Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Morquio Syndrome Treatment Business of Daiichi Sankyo (2019-2024)
    Table 110. Daiichi Sankyo Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Morquio Syndrome Treatment Downstream Customers
    Table 114. Morquio Syndrome Treatment Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Morquio Syndrome Treatment Product Picture
    Figure 2. Global Morquio Syndrome Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Morquio Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Morquio Syndrome Treatment Report Years Considered
    Figure 5. Global Morquio Syndrome Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Morquio Syndrome Treatment Revenue in 2023
    Figure 7. Morquio Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Morquio A Picture
    Figure 9. Morquio B Picture
    Figure 10. Global Morquio Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Morquio Syndrome Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinic
    Figure 14. Product Picture of Others
    Figure 15. Global Morquio Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Morquio Syndrome Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Morquio Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Morquio Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Morquio Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Morquio Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Morquio Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Morquio Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Morquio Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Morquio Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Morquio Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Morquio Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Morquio Syndrome Treatment Sales Value (%), (2019-2030)
    Figure 28. United States Morquio Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Morquio Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Morquio Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Morquio Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Morquio Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Morquio Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Morquio Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Morquio Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Morquio Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Morquio Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Morquio Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Morquio Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Morquio Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Morquio Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Morquio Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 49. Morquio Syndrome Treatment Industrial Chain
    Figure 50. Morquio Syndrome Treatment Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Gene Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-13C13054
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Sickle Cell Anemia Testing Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36I12524
Mon Mar 10 00:00:00 UTC 2025

Add to Cart

Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18M13082
Fri Mar 07 00:00:00 UTC 2025

Add to Cart

Global Marfan Syndrome Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18L9349
Tue Mar 04 00:00:00 UTC 2025

Add to Cart